Global Life Sciences Cluster Report 2011 - Jones Lang LaSalle
Global Life Sciences Cluster Report 2011 - Jones Lang LaSalle
Global Life Sciences Cluster Report 2011 - Jones Lang LaSalle
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
3rd<br />
13.6%<br />
2nd<br />
% life science<br />
employment<br />
18.6<br />
Emerging cluster<br />
Minneapolis<br />
15th<br />
Science and<br />
engineering<br />
students<br />
(per 1,000)<br />
$289.1<br />
NIH funding<br />
(in millions)<br />
Rank in relation to 16 United States clusters<br />
12th<br />
$131.4<br />
VC funding<br />
(in millions)<br />
60 Americas | <strong>Jones</strong> <strong>Lang</strong> <strong>LaSalle</strong><br />
8th<br />
3.0%<br />
9th<br />
State<br />
R&D spend<br />
(as % of GDP)<br />
3,530<br />
Research<br />
facilities<br />
(in thousands<br />
of square feet)<br />
Overview<br />
Overall rank based on quantitative data,<br />
among 16 United States clusters.<br />
Despite a lack of innovation-friendly<br />
incentives and programs, Minneapolis’s<br />
deep intellectual resources prime the<br />
region for growth and development.<br />
Minnesota’s economy is about 24 percent more dependent on the<br />
life sciences than the national average. Ventures in the area<br />
compete in a variety of industry sectors such as medical devices,<br />
biopharmaceuticals, animal health, agricultural biotechnology<br />
and biofuels. Over the past five years, Minnesota has outpaced<br />
the nation in the growth of its biobusiness technology industry.<br />
The workforce has increased by 20 percent with growth led by the<br />
medical devices sub-sector.<br />
Success in life sciences is anchored in the state’s agricultural and<br />
medical technology industries, but is made possible by the strength<br />
of its high-technology industries. In partnership with government<br />
and academia, these segments of the state’s industrial sector<br />
Tof C
Change language